Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Luis Nombela Franco, entitled “Transcatheter treatment of mitral valve regurgitation”
SOLACI-SOCIME 2022 | When is indicated the transcatheter treatment of mitral regurgitation
Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Márcio Montenegro, entitled “When is indicated the transcatheter treatment of mitral regurgitation”
SOLACI-SOCIME 2022 | Tricuspid Edge-to-edge repair. When the Triclip is indicated?
Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Luis Marroquín, entitled “Tricuspid Edge-to-edge repair. When the Triclip is indicated?”
The Best of the SOLACI-SOCIME 2022 Main Arena: Structural—Selected Topics of TAVR
On the last session from day 1 of SOLACI-SOCIME 2022 on structural pathology, Dr. Raj Makkar, an international expert on the subject, talked about transcatheter aortic valve replacement (TAVR) in pure aortic regurgitation (AR), which presents several implantation challenges, such as insufficient anchoring, embolization, residual regurgitation, ring rupture, etc. As opposed to patients with aortic…
The Best of the SOLACI-SOCIME 2022 Main Arena: Mitral Valve
During the “Mitral Valve” session (on the first day of the SOLACI-SOCIME 2022 Congress), Dr. Ignacio Amat Santos (SPA) delivered a great talk on transcatheter mitral valve replacement (TMVR). During his presentation, he discussed different scenarios for transcatheter replacement: mitral valve-in-vale, mitral valve-in-ring, mitral valve in MAC, and new devices for non-calcified native valves. When…
SOLACI-SOCIME 2022 | Percutaneous aortic valve implantation on a prosthetic valve (VIV). Interactive Educational Case
Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr.Mauricio Cohen entitled “Percutaneous aortic valve implantation on a prosthetic valve (VIV). Interactive Educational Case”
SOLACI-SOCIME 2022 | Practical demonstration of aortic valve implantation on native valve. STEP BY STEP
Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Alejandro Alcocer, entitled “Practical demonstration of aortic valve implantation on native valve. STEP BY STEP”
SOLACI-SOCIME 2022 | TAVI Edited Case, by Dra. Carla Agatiello
Enjoy this edited case performed by Dr. Carla Agatiello during the SOLACI-SOCIME 2022 Congress held at Expo Santa Fé, CDMX on August 4, 5 and 6, 2022. Topic: TAVI Edited Case, by Dra. Carla Agatiello
SOLACI-SOCIME 2022 | Calcified Annulus, by Dr. Guering Eid Lidt (LIVE IN A BOX CASE)
Enjoy this edited case performed by Dr. Guering Eid Lidt during the SOLACI-SOCIME 2022 Congress held at Expo Santa Fé, CDMX on August 4, 5 and 6, 2022. Topic: Calcified Annulus, by Dr. Guering Eid Lidt
TRICVALVE in Patients with Severe Tricuspid Regurgitation: Promising Results at 6 months
Severe tricuspid regurgitation (TR) is associated with high mortality and morbidity. For patients with high surgical risk that cannot get surgery, the endovascular option has become an attractive solution this past decade. Transcatheter intervention has focused on edge-to-edge repair and valve replacement. However, their success depends on anatomical characteristics and imaging guidance effectiveness. The bicaval…
Antithrombotic Therapy Post Percutaneous Left Atrial Appendage Closure
Percutaneous left atrial appendage closure (LAAO) with Watchman has FDA approval since March 2015, having shown, in the PROTECT-AF and PREVAIL studies, reduced risk of atrial fibrillation driven stroke, by excluding the left atrial appendage form systemic circulation. Both studies used post procedure standardized protocols involving followup at 45 days and 6 months, imaging, and…